Table 2.
Characteristics of histopathological, familial and multivitamin use status among BBD patients in placebo (n = 40) and intervention (n = 40) groups at the baseline of study
| Characteristics | Intervention(n = 40) | Placebo(n = 40) | p- value * |
|---|---|---|---|
| Histopathological characteristics | |||
| Fibrocystic | 34(85.0) ** | 35(87.5) | < 0.001 |
| Fibroadenoma | 6(15.0) | 5(12.5) | |
| Others | |||
| Family history of BC | |||
| No | 35(87.5) | 30(75.0) | < 0.001 |
| Positive | 5(12.5) | 10(25.0) | |
| Family history of BBD | |||
| No | 40(100.0) | 39(97.5) | < 0.001 |
| Positive | 0 | 1(2.5) | |
| Smoker | |||
| Never | 40(100) | 40(100) | N/A |
| Ever | 0 | 0 | |
| Current | 0 | 0 | |
| Multivitamin use | |||
| No | 38(95.0) | 35(87.5) | < 0.001 |
| Yes | 2(5.0) | 5(12.5) | |
| Duration of multivitamin use (months) | |||
| ≤2 | 1(50.0) | 3(60.0) | 0.680 |
| >2 | 1(50.0) | 2(40.0) | |
| Vitamin E capsule use | |||
| No | 22(55) | 25(62.5) | 0.11 |
| Yes | 18(45) | 15(37.5) | |
| Omega3 capsule use | |||
| No | 33(82.5) | 28(70) | < 0.001 |
| Yes | 7(17.5) | 12(30) | |
BC, breast cancer; BBD, benign breast disorders.
*
Chi-square test was performed.
**
Data was expressed in the form of number of participants (relative frequency, %).